Medical Oncologist
Kamishov Sergey Viktorovich
Chemotherapy
Professional summary
Dr. Kamishov heads the Outpatient Chemotherapy department and serves as chief chemotherapy consultant of the Ministry of Health of Uzbekistan. He specializes in the diagnosis and conservative treatment of cancer using chemotherapy, targeted therapy and immunotherapy. His practice follows international clinical protocols and standards (ESMO, NCCN, ASCO, RUSSCO).
Areas of expertise
- Drug treatment of cancer (chemotherapy, targeted, immuno- and hormone therapy)
- Personalized selection of anticancer treatment regimens
- Organization and improvement of cancer care
- Development and implementation of clinical protocols and standards
- Clinical trials of drugs in oncology in accordance with GCP standards
Education & training
Specialization in oncology, chemotherapy (2001)
Clinical internship in "General Medicine" (1998)
Student of the medical faculty, Tashkent State Medical Institute (1994–1996)
Student of the medical faculty, North Ossetian State Medical Institute, Vladikavkaz, Russia (1990–1994)
Certifications & licenses
Education and qualifications: Higher medical education, oncologist-chemotherapist of the highest qualification category (since 2015)
Academic degrees and titles: Doctor of Medical Sciences, Candidate of Medical Sciences, professor, senior researcher
Accreditation: Official accreditation at the Center for Advanced Medical Training of the Ministry of Health of Uzbekistan
Specialized training and fellowships:
Katholieke Universiteit Leuven (Leuven, Belgium)
Mayo Clinic Care Network (Hyderabad, India)
NHG-Johns Hopkins Singapore Institute (Singapore)
N.N. Blokhin RCRC (Moscow, Russia)
N.N. Petrov NMRC of Oncology (Saint Petersburg, Russia)
International recognition: Numerous diplomas and certificates of participation in international congresses and conferences
Certificates: ICH GCP R3 (2025)
Achievements & research
Honorary awards:
Badge "Distinguished Health Worker of the Republic of Uzbekistan"
Badge "30 Years of Independence of the Republic of Uzbekistan"
Publications:
Next-generation sequencing–based mutation profiling in solid tumors: A study from a north Indian tertiary care center. MI Ather, S Kamishov, D Pendharkar. Journal of Clinical Oncology (2026)
Effectiveness and safety of combined therapy with pemetrexed and bevacizumab in recurrent and metastatic cervical cancer. S Niyozova, K Izrailbekova, S Kamishov, O Kobilov. Journal of Clinical Oncology (2025)
Efficacy of Everolimus and Fulvestrant in Resistant Metastatic Breast Cancer: Experience from Uzbekistan. S Kamishov, K Izrailbekova, S Niyozova, O Kobilov. International Congress on Biological, Physical and Chemical Studies, Italy (2025)
Possibilities of long-term atezolizumab immunotherapy in patients with metastatic urothelial cancer. S Kamishov, M Tillyashaykhov, E Boyko, SK Niyozova, K Izrailbekova. Journal of Clinical Oncology (2024)
Immunohistochemical markers in the prognostic model for survival of patients with diffuse large B-cell lymphoma. O Kobilov, S Kamishov. Journal of Clinical Oncology (2024)
Reviewer of the journal "Eurasian journal of oncology and radiology"
Membership in international societies:
ESMO, IASLC, EAU, RUSSCO, AOUZ